CLINICAL_TRIALS
trial_result
· 2013-09-18
Clinical Trial Update: Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares [Phase 3]
Summary
Phase 3 trial evaluating the long-term prevention of diverticulitis flares with mesalamine has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SOFAR S.p.A. | Conditions: Diverticular Disease | Phase 3 | Status: COMPLETED